Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
She seems like a very aggressive CEO. Which you don't see to often in these companies.
And that's exactly why I buried this one
Like a well trained bloodhound...
Do you know what grow supply store?
Very diverse... Plenty of room for growth!
You best believe it!! BOOOOOOM POWWWWWW!!
I'm so excited I just replied this to myself..."lemme be more specific..when I say north I mean like to the moon north!!"
Lemme be more specific....when I say north I mean like moon north!! Lol
I'm in 100k shares strong...looking to bump that up though
All indicators will be north by noon
Oh that would be lovely
BOOM TIME!!
IMD making big moves and lots of em
Not selling a share! Hopefully I can get some more today
Nice!!!hold on to your hats!!
Looking to see the volume in the 10-15 mil range today and ill be happy....15+ and we may test previous high....
I need to double my shares dip or no dip
Very interesting...can't wait til the bell
Agreed...no delaying here. This one's gonna move quick
Nah...should be a nice end to the week for me
Chart is lookin pretty
First thing I do with all buys.... sell orders in..I hate shorters
Not gonna feel late come tomorrow
$PIHN NEWS !!
PLANO, Texas, April 22, 2014 /PRNewswire via COMTEX/ -- PLANO, Texas, April 22, 2014 /PRNewswire/ --
Polaris International Holdings, Inc. PIHN -5.29% has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.
Polaris is focused on the development of their ProCannas Product line and intends on utilizing some of the production of Hemp to be used for the production of such said line of products and the availability to enter into other markets as well.
The two companies will form a separate LLC of which each company will be members.
Kentucky passed SB50 in 2013 which removes hemp from the controlled substances list and allows for Kentucky farmers to cultivate the crop without fear of law enforcement. To read the entire bill visit http://www.lrc.ky.gov/record/13RS/SB50.htm
"With Kentucky's SB50 becoming law and allowing the growth of hemp, the opportunity to secure farmland for our benefit was necessary. By entering this joint venture, we are opening the door to establish our own supply of CBD for use in our ProCannas products. This will substantially reduce our production costs and therefore increase profitability for the Company." states Medical Director, Dr. Vasthi Alvarez Avila. Tentative plans for extraction of the CBDs from the growth production will be completed within Kentucky which will decrease delivery and production time.
The Company is also looking forward to the launch of its new website in the coming weeks which will have more detailed information on the company, production, and the ProCannas line of products.
ABOUT THE COMPANY
ProCannas core business focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc. http://www.Procannas.net +1-970-279-3478 Info@Procannas.net
SOURCE Polaris International Holdings, Inc.
Copyright (C) 2014 PR Newswire. All rights reserved
$PIHN NEWS!!
PLANO, Texas, April 22, 2014 /PRNewswire via COMTEX/ -- PLANO, Texas, April 22, 2014 /PRNewswire/ --
Polaris International Holdings, Inc. PIHN -5.29% has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.
Polaris is focused on the development of their ProCannas Product line and intends on utilizing some of the production of Hemp to be used for the production of such said line of products and the availability to enter into other markets as well.
The two companies will form a separate LLC of which each company will be members.
Kentucky passed SB50 in 2013 which removes hemp from the controlled substances list and allows for Kentucky farmers to cultivate the crop without fear of law enforcement. To read the entire bill visit http://www.lrc.ky.gov/record/13RS/SB50.htm
"With Kentucky's SB50 becoming law and allowing the growth of hemp, the opportunity to secure farmland for our benefit was necessary. By entering this joint venture, we are opening the door to establish our own supply of CBD for use in our ProCannas products. This will substantially reduce our production costs and therefore increase profitability for the Company." states Medical Director, Dr. Vasthi Alvarez Avila. Tentative plans for extraction of the CBDs from the growth production will be completed within Kentucky which will decrease delivery and production time.
The Company is also looking forward to the launch of its new website in the coming weeks which will have more detailed information on the company, production, and the ProCannas line of products.
ABOUT THE COMPANY
ProCannas core business focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc. http://www.Procannas.net +1-970-279-3478 Info@Procannas.net
SOURCE Polaris International Holdings, Inc.
Copyright (C) 2014 PR Newswire. All rights reserved
$pihn news!!
PLANO, Texas, April 22, 2014 /PRNewswire via COMTEX/ -- PLANO, Texas, April 22, 2014 /PRNewswire/ --
Polaris International Holdings, Inc. PIHN -5.29% has entered into a revolutionary agreement with a 70 acre hemp farm in Kentucky. The agreement provides for Polaris to secure 100% of the harvested material for the extraction of cannabinoids.
Polaris is focused on the development of their ProCannas Product line and intends on utilizing some of the production of Hemp to be used for the production of such said line of products and the availability to enter into other markets as well.
The two companies will form a separate LLC of which each company will be members.
Kentucky passed SB50 in 2013 which removes hemp from the controlled substances list and allows for Kentucky farmers to cultivate the crop without fear of law enforcement. To read the entire bill visit http://www.lrc.ky.gov/record/13RS/SB50.htm
"With Kentucky's SB50 becoming law and allowing the growth of hemp, the opportunity to secure farmland for our benefit was necessary. By entering this joint venture, we are opening the door to establish our own supply of CBD for use in our ProCannas products. This will substantially reduce our production costs and therefore increase profitability for the Company." states Medical Director, Dr. Vasthi Alvarez Avila. Tentative plans for extraction of the CBDs from the growth production will be completed within Kentucky which will decrease delivery and production time.
The Company is also looking forward to the launch of its new website in the coming weeks which will have more detailed information on the company, production, and the ProCannas line of products.
ABOUT THE COMPANY
ProCannas core business focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc. http://www.Procannas.net +1-970-279-3478 Info@Procannas.net
SOURCE Polaris International Holdings, Inc.
Copyright (C) 2014 PR Newswire. All rights reserved
Slappin the ask
Gonna be a good day
I don't usually buy on open but today I'm gonna make an exception
Lets break that wall at 248....
$pinn exciting news
$pihn I'm expecting a big day here! BOOOOOOOM!
Yes sir...I expect it to continue
Only 8oz??? U must not be too hungry tonight..lol
That they do..dying to see what else they have in store!
This isn't a "fly by night" company. They're doing real things, to help real people
Absolutely not! I have a boatload of confidence in this company
$pihn... speaks volume:
PLANO, TX, Apr 09, 2014 (Marketwired via COMTEX) -- Polaris International Holdings, Inc. (otc pink:PIHN) (pinksheets:PIHN) is excited to announce its medical division, ProCannas, is opening three new sales offices in Tampa, FL; Vancouver, British Columbia, Canada; and Mexico City, Mexico in the Summer of 2014. The Company is also exploring the possibility of distribution channels in select areas throughout India and Asia.
The Company has received multiple requests from Physicians in Tampa and other parts of Florida to begin trials with our transdermal cannabinoid patch. The Company's sales offices will assist the Physicians with implementation of the trials using the Company's proprietary tracking software.
"The Company believes that establishing these sales locations will provide more efficient customer service to our participating physicians and be more economically favorable to the Company's bottom line. Physicians feel more comfortable having a sales and service person in the area rather than a customer service representative over the phone," states Medical Director Dr. Vasthi Alvarez Avila.
ABOUT THE COMPANY
ProCannas' core business focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc. WWW.Procannas.net Info@Procannas.net
Grabbed some at .017 today...gonna dump some dogs for more first thing in the a.m.